OZA 0.23 mg Pill - gray capsule/oblong
Generic Name: ozanimod
Pill with imprint OZA 0.23 mg is Gray, Capsule/Oblong and has been identified as Zeposia 0.23 mg. It is supplied by Bristol-Myers Squibb Company.
Zeposia is used in the treatment of Ulcerative Colitis; Multiple Sclerosis and belongs to the drug class selective immunosuppressants. Zeposia 0.23 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for OZA 0.23 mg
Zeposia
- Generic Name
- ozanimod
- Imprint
- OZA 0.23 mg
- Strength
- 0.23 mg
- Color
- Gray
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb Company
- National Drug Code (NDC)
More about Zeposia (ozanimod)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
